Company

Olympus Terumo Biomaterials Corporation

Olympus Terumo Biomaterials develops and manufactures biomaterials, including artificial bone substitutes.

About

Olympus Terumo Biomaterials researches, develops, manufactures, and sells biomaterials, including products for knee osteotomy, spine surgery, and bone replacement. Founded in 2004, the company is based in Tokyo, Japan. In May 2024, Polaris Capital Group acquired an undisclosed stake. Manabu Ishikawa was CEO as of June 2024.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in